November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

UCLA Health Researchers Use CRISPR to Target Genetic Mechanisms in Autism Models

🧠 AI Analysis 2 min read 👁 6

Scientists at UCLA Health have demonstrated in lab-grown human brain cells that increasing the activity of a healthy gene copy can offset autism-linked mutations, offering a potential new therapeutic avenue.

UCLA Health Researchers Use CRISPR to Target Genetic Mechanisms in Autism Models🧠AI Analysis

Photo: Medical Xpress

Key points

  • UCLA researchers targeted CHD8 and SCN2A genes using modified CRISPR.
  • The method boosts the healthy gene copy to compensate for a mutated counterpart.
  • Testing was performed exclusively on lab-grown human neurons and cortical organoids.

A team of investigators at UCLA Health has successfully used a modified form of CRISPR in laboratory-grown human brain cells to boost the expression of healthy gene copies, mitigating the impact of specific mutations associated with autism spectrum disorder. Published in Nature Neuroscience, the study introduces a novel strategy for targeting the biological roots of neurodevelopmental conditions rather than merely managing outward symptoms, though the methodology remains in early laboratory testing.

Many cases of autism involve genetic alterations where one of two gene copies is deactivated, a situation where a single remaining copy often fails to produce sufficient protein for typical brain development. Led by Dr. Daniel Geschwind, the research group focused specifically on two high-risk genes, CHD8 and SCN2A. Instead of attempting to replace or directly edit the mutated DNA, the scientists utilized modified CRISPR technology to target enhancers—DNA regulatory elements that function like dials to govern gene activity—thereby elevating the output of the healthy copy without triggering excessive overexpression.

The experimental approach was evaluated using stem cell-derived excitatory neuron cultures and cortical organoids, which replicate early human brain development. According to first author George Chen, the intervention demonstrated high precision by acting exclusively on mutated cell lines while leaving healthy controls unaffected. Nevertheless, researchers caution that these findings represent an initial proof of concept. Substantial hurdles remain, including the development of safe delivery systems for the human brain and determining efficacy beyond early developmental windows. Patients should consult healthcare professionals for personalized guidance regarding medical conditions.

  • What to know: UCLA Health researchers used modified CRISPR on lab models to boost healthy gene copies linked to autism.
  • The technique selectively increased expression in mutated cell lines without disrupting healthy ones.
  • The research is in early preclinical stages and requires significant development before clinical application.

Source Medical Xpress — medicalxpress.com/news/2026-11-approach-autism-conditions-faulty-gene.h… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.